Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
29 Oct 2026Enliven TherapeuticsUnited StatesA Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIsPhase 3Recruiting29 Oct 2026Exir Gene PharmedIranSPX-01 Gene Therapy in Pediatric Patients With Spinal Muscular Atrophy Type 1 (RISE)Early Phase 1Not Yet Recruiting29 Oct 2026Fitbit LLCUnited StatesCare COMPASS StudyNot applicableNot Yet Recruiting29 Oct 2026Genbioma Aplicaciones SLSpainEfficacy of the pA1c®HI Postbiotic in Metabolic Regulation in Healthy Individuals With HyperglycemiaEarly Phase 1Not Yet Recruiting29 Oct 2026GlaxoSmithKlineA Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult ParticipantsPhase 1Not Yet Recruiting29 Oct 2026Guangdong ProCapZoom Biosciences Co., Ltd.A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases.Phase 1Not Yet Recruiting29 Oct 2026Guizhou Sinorda Pharmaceutical Co., Ltd.ChinaSND002 Cell Injection in Participants With Advanced Malignant Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Inmunotek S.L.Portugal, SpainSpecific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-069.Phase 3Recruiting29 Oct 2026Inmunotek S.L.Portugal, SpainSpecific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.Phase 3Recruiting29 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaA Study of IBI3043 Treatment in Participants With Locally Advanced, Unresectable or Metastatic Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Jade Biosciences, Inc.United StatesA Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A NephropathyPhase 3Recruiting29 Oct 2026Janssen Research & Development, LLCA Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant EligiblePhase 3Not Yet Recruiting29 Oct 2026Jiangsu Simcere Pharmaceutical Co., Ltd.A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic StrokePhase 2, Phase 3Not Yet Recruiting29 Oct 2026JS Health & VitaminsUnited StatesA Clinical Trial to Examine the Effects of Gut Health Supplements to Improve Gut and Digestive Health and FunctionNot applicableCompleted29 Oct 2026Kite, A Gilead CompanyTo Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaPhase 3Not Yet Recruiting29 Oct 2026Laboratoires ARIONFranceEvaluation of the Performance and Safety of the Monobloc® - Silicone SoftOne® Breast Implants at 10 YearsActive Not Recruiting29 Oct 2026Mabsoft Therapeutics (Shanghai) Co., Ltd.AustraliaPhase Ia Study of MST-931 in Healthy Adult SubjectsPhase 1Recruiting29 Oct 2026North Immunology Inc.AustraliaA Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic DermatitisPhase 1Not Yet Recruiting29 Oct 2026OBS Medical LtdImproving Deceased Organ Donation and Transplantation Using the Donation Advisor Clinical Decision Support ToolNot applicableNot Yet Recruiting29 Oct 2026Otsuka Pharmaceutical Development & Commercialization, Inc.Trial of VIS954 in the Treatment of Antineutrophil Cytoplasmic Antibody-associated VasculitisPhase 2Not Yet Recruiting29 Oct 2026PfizerUnited StatesA Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.Phase 1Recruiting29 Oct 2026Prelude Therapeutics IncorporatedUnited StatesA Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast CancerPhase 1Recruiting29 Oct 2026Primal Harvest, LLCUnited StatesA Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-beingNot applicableNot Yet Recruiting29 Oct 2026SanofiNetherlandsA Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Netherlands)Completed29 Oct 2026SanofiA Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic DermatitisPhase 4Not Yet Recruiting29 Oct 2026SanofiSpainA Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Spain)Active Not Recruiting29 Oct 2026Schweitzer Engineering LaboratoriesUnited StatesEffectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine HealthcareRecruiting29 Oct 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaHB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial CancerPhase 3Recruiting29 Oct 2026Shanghai Mabgeek Biotech.Co.LtdA Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal PolypsPhase 3Not Yet Recruiting29 Oct 2026Shanghai YingLi Pharmaceutical Co. Ltd.First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of YL-18319 Monotherapy in Patients With Locally Advanced/Metastatic Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Sinocelltech Ltd.ChinaPhase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis BPhase 1Not Yet Recruiting29 Oct 2026Superluminal Medicines, Inc.A Study of Safety of SUN-0864 and How it is Processed by and Affects the Body in Healthy Adults and Healthy Adults Who Are Overweight or Obese.Phase 1Not Yet Recruiting29 Oct 2026TakedaA Study About Treatment Use in Adults With Narcolepsy Type 1 (NT1) in Europe and CanadaNot Yet Recruiting29 Oct 2026Vigonvita Life SciencesChinaA Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's DiseasePhase 2Not Yet Recruiting29 Oct 2026X4 PharmaceuticalsA Study to Investigate the Safety and Tolerability of Granulocyte-colony Stimulating Factor (G-CSF) Dosage Reduction in Mavorixafor-treated Participants With Acquired Primary Autoimmune and Idiopathic Chronic Neutropenia DisordersPhase 2Not Yet Recruiting28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting ConditionsPhase 1Not Yet Recruiting28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult VolunteersPhase 1Not Yet Recruiting28 Oct 2026Alkermes, Inc.United StatesA Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive DisorderPhase 2Recruiting28 Oct 2026Ambulanzpartner Soziotechnologie APST GmbHGermanyRegister for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System DisordersRecruiting28 Oct 2026Anhui HygeianCells BioMedical Co., Ltd.ChinaA Single-Center Phase 1 Study of ceAF for Knee Osteoarthritis (KOA)Phase 1Recruiting28 Oct 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaEvaluation of ICP-B381 in Patients With Advanced Solid TumorsPhase 1, Phase 2Recruiting28 Oct 2026Biohaven Therapeutics Ltd.An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' DiseasePhase 2, Phase 3Not Yet Recruiting28 Oct 2026BTL Industries Ltd.CzechiaVacuum Compression Therapy and Tissue Oxygenation in Chronic Leg UlcersNot applicableRecruiting28 Oct 2026Cajal Therapeutics Inc.AustraliaStudy of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney DiseasePhase 1Not Yet Recruiting28 Oct 2026CytomX TherapeuticsStudy of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal CancerPhase 1, Phase 2Not Yet Recruiting28 Oct 2026Dime Beauty Co.United StatesA Clinical Study to Assess the Effectiveness of the Hyper Glow Serum on Skin Complexion and HydrationNot applicableCompleted28 Oct 2026Dime Beauty Co.United StatesA Clinical Study to Assess the Effects of a Dark Spot Corrector on Dark Spots and Overall ComplexionNot applicableCompleted28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting28 Oct 2026Hamad Medical CorporationJordan, Oman, QatarMiddle East Study of Infections in Patients With Hematological MalignanciesRecruiting28 Oct 2026Helixon Biotechnology (Suzhou) Co., LtdAustraliaStudy of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPhase 1Not Yet Recruiting// How AOS uses this